D
Donald Stablein
Researcher at Medical College of Wisconsin
Publications - 93
Citations - 12817
Donald Stablein is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 47, co-authored 93 publications receiving 12161 citations.
Papers
More filters
Journal ArticleDOI
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm,Punnee Pitisuttithum,Sorachai Nitayaphan,Jaranit Kaewkungwal,Joseph Chiu,Robert Paris,Nakorn Premsri,Chawetsan Namwat,Mark de Souza,Elizabeth Adams,Michael Benenson,Sanjay Gurunathan,Jim Tartaglia,John G. McNeil,Donald P. Francis,Donald Stablein,Deborah L. Birx,Supamit Chunsuttiwat,Chirasak Khamboonruang,Prasert Thongcharoen,Merlin L. Robb,Nelson L. Michael,Prayura Kunasol,Jerome H. Kim +23 more
TL;DR: This ALVAC-HIV and AIDSVAX B/E vaccine regimen may reduce the risk of HIV infection in a community-based population with largely heterosexual risk and offer insight for future research.
Journal ArticleDOI
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
Sundaram Hariharan,Christopher P. Johnson,Barbara A. Bresnahan,S. Taranto,Matthew McIntosh,Donald Stablein +5 more
TL;DR: There has been a substantial increase in short-term and long-term survival of kidney grafts from both living and cadaveric donors since 1988.
Journal ArticleDOI
Oral immunotherapy for treatment of egg allergy in children.
A. Wesley Burks,Stacie M. Jones,Robert A. Wood,David Fleischer,Scott H. Sicherer,Robert Lindblad,Donald Stablein,Alice K. Henning,Brian P. Vickery,Andrew H. Liu,Amy M. Scurlock,Wayne G. Shreffler,Marshall Plaut,Hugh A. Sampson +13 more
TL;DR: These results show that oral immunotherapy can desensitize a high proportion of children with egg allergy and induce sustained unresponsiveness in a clinically significant subset.
Journal ArticleDOI
Outcomes of Kidney Transplantation in HIV-Infected Recipients
Peter G. Stock,Burc Barin,Barbara Murphy,Douglas W. Hanto,Jorge Diego,Jimmy A. Light,Charles E. L. B. Davis,Emily A. Blumberg,David Simon,Aruna Subramanian,J. Michael Millis,G. Marshall Lyon,Kenneth L. Brayman,Doug Slakey,Ron Shapiro,Joseph K. Melancon,Jeffrey M. Jacobson,Valentina Stosor,Jean L. Olson,Donald Stablein,Michelle E. Roland +20 more
TL;DR: In this cohort of carefully selected HIV-infected patients, both patient- and graft-survival rates were high at 1 and 3 years, with no increases in complications associated with HIV infection.
Journal ArticleDOI
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch,Dan H. Barouch,Jinyan Liu,Hualin Li,Lori F. Maxfield,Peter Abbink,Diana M. Lynch,M. Justin Iampietro,Adam J. SanMiguel,Michael S. Seaman,Guido Ferrari,Donald N. Forthal,Ilnour Ourmanov,Vanessa M. Hirsch,Angela Carville,Keith G. Mansfield,Donald Stablein,Maria G. Pau,Hanneke Schuitemaker,Jerald C. Sadoff,Erik Billings,Mangala Rao,Merlin L. Robb,Jerome H. Kim,Mary A. Marovich,Jaap Goudsmit,Nelson L. Michael +26 more
TL;DR: The proof-of-concept that optimized HIV-1 vaccine candidates can block acquisition of stringent, heterologous, neutralization-resistant virus challenges in rhesus monkeys is demonstrated.